from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0250c/-

LFCtreatmentdescriptionclass of inhibitor

-0.009

Amikacinug/mL Amikacintranslation

-0.864

Cap5-10ug/mL Capreomycintranslation

-2.241

Rox10-50 ug/mL Roxithromycintranslation

1.738

SM2-5 ug/mL Streptomycintranslation

-0.339

Tet5-10 ug/mL Tetracyclinetranslation

-0.964

Rif0.2-5ug/mL Rifampicintranscription

-0.581

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.370

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.912

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.438

CPZ10-50 ug/mL Chlorpromazinerespiration

-2.086

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.335

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.917

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.424

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.278

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.340

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.220

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.605

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-2.351

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.388

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.263

KCN5-20 ug/mL Potassium cyaniderespiration

-1.260

NaN30.2-2 mM Sodium aziderespiration

-0.782

Nigericin50 uM Nigericinrespiration

-0.335

TRC10-150 ug/mL Triclosanrespiration

0.633

TRZ10-25 ug/mL Thioridazinerespiration

-0.444

Valinomycin0.5-10 uM Valinomycinrespiration

-0.222

ZnSO42 mM ZnSO4respiration

1.797

menadione6-10 ug/mL Menadionerespiration

-0.844

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.188

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.957

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.422

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.043

NRP_1Non-replicating persistence stage 1dosRassociated

0.522

Amp0.2mg/mL AmpicillincellWall

0.377

Cephalexin20-100 ug/mL CephalexincellWall

-0.491

Cerulenin0.32-5 ug/mL CerulenincellWall

0.412

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.005

EMB10-20 ug/mL EthambutolcellWall

-0.292

Eta12-40 ug/mL EthionamidecellWall

-0.251

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.399

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.312

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.228

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.110

BZA0.12 mg/mL BenzamidearomaticAmides

1.251

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.856

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.671

H2O24 mM hydrogen peroxideDNAdamaging

0.713

Levo10 ug/mL LevofloxacinDNAdamaging

0.111

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.385

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.576

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.319

UVUV-irradiationDNAdamaging

1.072

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.242

Antimycin12.5-50 ug/mL Antimycin A?

0.301

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.029

PA_110-50 ug/mL Antitubercular compound PA-1?

0.151

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.721

PA8240.2-2 ug/mL PA-824?

-1.171

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.105

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.537

Verapamil50 uM Verapamil?

0.302

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.555

methoxatin10-20 ug/mL Methoxatin?